Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/61256
Full metadata record
DC FieldValueLanguage
dc.contributor.authorThanyawee Puthanakiten_US
dc.contributor.authorLinda Aurpibulen_US
dc.contributor.authorPeninnah Oberdorferen_US
dc.contributor.authorNoppadon Akarathumen_US
dc.contributor.authorSuparat Kanjanavaniten_US
dc.contributor.authorPornphun Wannariten_US
dc.contributor.authorThira Sirisanthanaen_US
dc.contributor.authorVirat Sirisanthanaen_US
dc.date.accessioned2018-09-10T04:07:34Z-
dc.date.available2018-09-10T04:07:34Z-
dc.date.issued2007-10-01en_US
dc.identifier.issn08913668en_US
dc.identifier.other2-s2.0-34848919230en_US
dc.identifier.other10.1097/INF.0b013e318125720aen_US
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34848919230&origin=inwarden_US
dc.identifier.urihttp://cmuir.cmu.ac.th/jspui/handle/6653943832/61256-
dc.description.abstractWe report the long-term efficacy of highly active antiretroviral therapy (HAART) in 107 antiretroviral-naive human immunodeficiency virus (HIV)-infected Thai children. In an intention-to-treat analysis, 70% of the children had undetectable HIV RNA titers after 192 weeks of HAART. The mean CD4 cell percentage increased from 5.3% to 26.6%. HAART is effective for HIV-infected children in this resource-poor setting despite initiation of treatment in the advanced stage of disease. © 2007 Lippincott Williams & Wilkins, Inc.en_US
dc.subjectMedicineen_US
dc.titleSustained immunologic and virologic efficacy after four years of highly active antiretroviral therapy in human immunodeficiency virus infected children in Thailanden_US
dc.typeJournalen_US
article.title.sourcetitlePediatric Infectious Disease Journalen_US
article.volume26en_US
article.stream.affiliationsChiang Mai Universityen_US
article.stream.affiliationsThailand Ministry of Public Healthen_US
Appears in Collections:CMUL: Journal Articles

Files in This Item:
There are no files associated with this item.


Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.